|
1
|
Lacroix A: Approach to the patient with
adrenocortical carcinoma. J Clin Endocrinol Metab. 95:4812–4822.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zini L, Porpiglia F and Fassnacht M:
Contemporary management of adrenocortical carcinoma. Eur Urol.
60:1055–1065. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fassnacht M, Libé R, Kroiss M and Allolio
B: Adrenocortical carcinoma: a clinician’s update. Nat Rev
Endocrinol. 7:323–335. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ng L and Libertino JM: Adrenocortical
carcinoma: diagnosis, evaluation and treatment. J Urol. 169:5–11.
2003. View Article : Google Scholar
|
|
5
|
Roman S: Adrenocortical carcinoma. Curr
Opin Oncol. 18:36–42. 2006. View Article : Google Scholar
|
|
6
|
Crucitti F, Bellantone R, Ferrante A, et
al: The Italian Registry for Adrenal Cortical Carcinoma: analysis
of a multiinstitutional series of 129 patients. The ACC Italian
Registry Study Group. Surgery. 119:161–170. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Icard P, Goudet P, Charpenay C, et al:
Adrenocortical carcinomas: surgical trends and results of a
253-patient series from the French Association of Endocrine
Surgeons study group. World J Surg. 25:891–897. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tauchmanovà L, Colao A, Marzano LA, et al:
Andrenocortical carcinomas: twelve-year prospective experience.
World J Surg. 28:896–903. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Decorato JW, Gruber H, Petti M and
Levowitz BS: Adrenal carcinosarcoma. J Surg Oncol. 45:134–136.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fischler DF, Nunez C, Levin HS, et al:
Adrenal carcinosarcoma presenting in a woman with clinical signs of
virilization. A case report with immunohistochemical and
ultrastructural findings. Am J Surg Pathol. 16:626–631. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sasaki K, Desimone M, Rao HR, et al:
Adrenocortical carcinosarcoma: a case report and review of the
literature. Diagn Pathol. 5:512010.PubMed/NCBI
|
|
12
|
Thway K, Olmos D, Shah C, et al: Oncocytic
adrenal cortical carcinosarcoma with pleomorphic
rhabdomyosarcomatous metastases. Am J Surg Pathol. 36:470–477.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barksdale SK, Marincola FM and Jaffe G:
Carcinosarcoma of the adrenal cortex presenting with
mineralocorticoid excess. Am J Surg Pathol. 17:941–945. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Okazumi S, Asano T, Ryu M, et al: Surgical
resection of adrenal carcinoma extending into the vena cava, right
atrium and ventricle: case report and review of the literature.
Nihon Geka Gakkai Zasshi. 88:231–238. 1987.(In Japanese).
PubMed/NCBI
|
|
15
|
Collina G, Maldarizzi F, Betts CM and
Eusebi V: Primary sarcomatoid carcinoma of the adrenal gland. First
case report. Virchows Arch A Pathol Anat Histopathol. 415:161–167.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee MS, Park IA, Chi JG, et al: Adrenal
carcinosarcoma - a case report. J Korean Med Sci. 12:374–377. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sturm N, Moulai N, Laverrière MH, et al:
Primary adrenocortical sarcomatoid carcinoma: case report and
review of literature. Virchows Arch. 452:215–219. 2008. View Article : Google Scholar
|
|
18
|
Coli A, Di Giorgio A, Castri F, et al:
Sarcomatoid carcinoma of the adrenal gland: a case report and
review of literature. Pathol Res Pract. 206:59–65. 2010. View Article : Google Scholar
|
|
19
|
Bertolini F, Rossi G, Fiocchi F, et al:
Primary adrenal gland carcinosarcoma associated with metastatic
rectal cancer: a hitherto unreported collision tumor. Tumori.
97:27e–30e. 2011.PubMed/NCBI
|
|
20
|
Kao CS, Grignon DJ, Ulbright TM and Idrees
MT: A case report of adrenocortical carcinosarcoma with oncocytic
and primitive neuroectodermal-like features. Hum pathol.
44:1947–1955. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miettinen M: Neuroendocrine
differentiation in adrenocortical carcinoma. New
immunohistochemical findings supported by electron microscopy. Lab
Invest. 66:169–174. 1992.PubMed/NCBI
|
|
22
|
Hoang MP, Ayala AG and Albores-Saavedra J:
Oncocytic adrenocortical carcinoma: a morphologic,
immunohistochemical and ultrastructural study of four cases. Mod
Pathol. 15:973–978. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jorda M, De MB and Nadji M: Calretinin and
inhibin are useful in separating adrenocortical neoplasms from
pheochromocytomas. Appl Immunohistochem Mol Morphol. 10:67–70.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghorab Z, Jorda M, Ganjei P and Nadji M:
Melan A (A103) is expressed in adrenocortical neoplasms but not in
renal cell and hepatocellular carcinomas. Appl Immunohistochem Mol
Morphol. 11:330–333. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang PJ, Genega EM, Tomaszewski JE, et
al: The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in
differentiating adrenal cortical and medullary tumors: an
immunohistochemical study. Mod Pathol. 16:591–597. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan CC, Chen PC, Tsay SH and Ho DM:
Differential immunoprofiles of hepatocellular carcinoma, renal cell
carcinoma, and adrenocortical carcinoma: a systemic
immunohistochemical survey using tissue array technique. Appl
Immunohistochem Mol Morphol. 13:347–352. 2005. View Article : Google Scholar : PubMed/NCBI
|
